glp-1 obesity drugs news today 2025 Market Industry Trends and Global Forecasts GLP-1 Pipeline Update: August 2025
Description
Orforglipron doesnt have any restrictions in terms of food intake or the time you take it, says Julio Rosenstock, MD, the lead author of the new study, the director of Velocity Clinical Research, and a professor at the University of Texas Southwestern Medical Center in Dallas
[DOI] [PMC free article] [PubMed] [Google Scholar] 82.Gault VA, Kerr BD, Harriott P, Flatt PR
Nature 533 (7602), 274277
With over 10 new indications under development, Vyvgarts peak sales may exceed $10 billion
Feldman-Billard S, Larger , Massin P
Of the incretin-based therapies, GLP-1 receptor agonists (GLP-1RAs) directly activate receptors, whereas dipeptidyl peptidase 4 (DPP-4) inhibitors exert their action by preventing degradation of endogenous GLP-1 and GIP 7
